COLL
COLLEGIUM PHARMACEUTICAL, INC
Key Financials
Gross Profit
$463.3M
↑ 260.9%
Operating Income
$179.6M
↑ 195.7%
Net Income
$62.9M
↑ 270.6%
EPS (Diluted)
$1.73
↑ 276.1%
Revenue
$780.6M
↑ 279.9%
Total Assets
$1.7B
↓ 0.4%
Shareholders' Equity
$301.7M
↑ 31.8%
Total Liabilities
$1.4B
↓ 5.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COLL |
| Company Name | COLLEGIUM PHARMACEUTICAL, INC |
| CIK | 1267565 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | VA |
| Phone | 781-713-3699 |